1. karmakid17
2. roseannhogan
3. mpee3438
1.roseannhogan 02/06/2018
Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program
2.mpee3438 01/23/2018
Waking up from a nap to see this, great
3.karmakid17 01/23/2018
Yep :(
4.karmakid17 01/26/2018
prices 5.75M share offering at $35
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW